Related Experiment Video

Updated: Aug 20, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis

Xiaoyan Wang1, Jian-Ping Wang, Maureen F Maughan

  • 1Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. xywang@mdanderson

Breast Cancer Research : BCR
|January 12, 2005
PubMed
Abstract

Insights

A novel Venezuelan equine encephalitis virus vaccine (VRP-neu) shows promise in preventing HER2/neu-expressing breast cancer. This active immunotherapy approach generated strong immune responses and prevented tumor growth and death in preclinical models.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • HER2/neu gene overexpression in breast cancer correlates with metastasis and poor prognosis.
  • Trastuzumab (Herceptin) offers passive immunotherapy but may be less effective than active vaccination.
  • Active immunotherapy via vaccines can induce T-cell and humoral immunity for enhanced cancer treatment.

Purpose of the Study:

  • To evaluate the efficacy of a novel vaccine for HER2/neu-positive breast cancer.
  • To test an active immunotherapeutic approach using virus-like replicon particles (VRP) carrying the HER2/neu gene (VRP-neu).

Main Methods:

  • Developed VRP-neu, a Venezuelan equine encephalitis virus-based vaccine encoding the HER2/neu gene.
  • Tested VRP-neu in preclinical tumor prevention and metastasis models.
  • Assessed tumor growth inhibition, tumor formation, survival rates, and immune responses (CD8+ T lymphocytes, serum IgG).

Main Results:

  • VRP-neu vaccination prevented or significantly inhibited the growth of HER2/neu-expressing murine breast cancer cells.
  • Complete prevention of tumor formation and death was observed in MMTV-c-neu transgenic mice.
  • Vaccination induced high levels of neu-specific CD8+ T lymphocytes and serum IgG.

Conclusions:

  • The VRP-neu vaccine demonstrates significant potential as an active immunotherapy for HER2/neu-positive breast cancer.
  • Preclinical findings support the clinical investigation of VRP-neu in patients.
  • This vaccine-induced immune response could offer a more effective therapeutic strategy.

More Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...